Abstract
ObjectiveInterval cytoreduction following neoadjuvant chemotherapy is a well-recognized treatment alternative to primary debulking surgery in the treatment of advanced epithelial ovarian cancer where patient and/or disease factors prevent complete macroscopic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have